Members Wealth’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$381K Sell
15,812
-136,987
-90% -$3.31M 0.19% 77
2026
Q2
$3.7M Buy
152,799
+14,814
+11% +$358K 2.03% 11
2026
Q1
$3.34M Sell
137,985
-7,880
-5% -$191K 2% 10
2025
Q4
$3.55M Buy
145,865
+12,807
+10% +$311K 2.22% 10
2025
Q3
$3.23M Buy
+133,058
New +$3.23M 2.05% 12
2025
Q1
$748K Buy
30,946
+139
+0.5% +$3.34K 0.56% 43
2024
Q4
$738K Buy
+30,807
New +$742K 0.55% 41
2024
Q2
$764K Buy
+31,650
New +$748K 0.51% 41

Other funds holding IBDS

Members Wealth's IBDS Position: Q3 2026 in Review

Members Wealth reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 90% in Q3 2026, selling an estimated $3.31M and leaving 15,812 shares worth $381K. The position accounts for 0.19% of the portfolio, ranked #77.

Members Wealth first reported a position in IBDS in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.7M in Q2 2026. 213 funds tracked by Wall St. Rank hold IBDS as of Q3 2026.

  • Members Wealth held 15,812 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $381K as of Q3 2026.
  • Members Wealth sold 136,987 iShares iBonds Dec 2027 Term Corporate ETF shares in Q3 2026, an estimated $3.31M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 0.19% of Members Wealth's portfolio in Q3 2026, its #77 holding.
  • Members Wealth first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2024 and has held it in 8 quarters since.
  • Members Wealth's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $3.7M in Q2 2026.
  • 213 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q3 2026.

Based on Members Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.